Exercise hemodynamic evaluation in the management of dasatinib-related pulmonary arterial hypertension: a case report
Abstract Background Dasatinib-related pulmonary arterial hypertension is a rare complication of chronic therapy for hematological malignancies. Pulmonary hypertension often persists despite drug discontinuation and might require vasodilators. Normalizing pulmonary hemodynamics and avoiding the long-...
Saved in:
| Main Authors: | Shuhei Yamashita, Takahiro Hiraide, Yasuyuki Shiraishi, Yoshinori Katsumata, Masaharu Kataoka, Shogo Fukui, Michiyuki Kawakami, Shinsuke Yuasa, Shinichiro Okamoto, Keiichi Fukuda, Masaki Ieda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Journal of Medical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13256-025-05221-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is Inducible Nitric Oxide Synthase (iNOS) Promising as a New Target Against Pulmonary Hypertension?
by: Piotr Ryszkiewicz, et al.
Published: (2025-03-01) -
Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia
by: E. G. Lomaia, et al.
Published: (2014-07-01) -
Performance of Risk‐Stratification Scores for Patients With Pulmonary Arterial Hypertension in a Multi‐Ethnic Asian Population
by: Haowen Jiang, et al.
Published: (2025-01-01) -
The Epidemiology, Burden, Risk Factors, Presentations, and Challenges of Evaluating and Managing Patients with Pulmonary Hypertension in Nigeria – A Short Review
by: Oluwafemi Tunde Ojo, et al.
Published: (2024-12-01) -
Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double‐blind placebo‐controlled study
by: Dunbar Ivy, et al.
Published: (2021-07-01)